DBV Technologies (DBVT) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -12.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.52% |
| Dec 31, 2025 | -11.68% |
| Sep 30, 2025 | -9.95% |
| Jun 30, 2025 | -10.99% |
| Mar 31, 2025 | -14.33% |
| Dec 31, 2024 | -14.59% |
| Sep 30, 2024 | -12.34% |
| Jun 30, 2024 | -14.47% |
| Mar 31, 2024 | -15.66% |
| Dec 31, 2023 | -20.15% |
| Jun 30, 2023 | -16.06% |
| Dec 31, 2022 | -15.08% |
| Sep 30, 2022 | -15.74% |
| Jun 30, 2022 | -12.61% |
| Dec 31, 2021 | -7.70% |
| Jun 30, 2021 | -0.34% |
| Dec 31, 2020 | 5.74% |
| Jun 30, 2020 | 12.17% |
| Dec 31, 2019 | 22.30% |
| Jun 30, 2019 | 26.36% |
| Dec 31, 2018 | 55.67% |
| Jun 30, 2018 | 101.73% |
| Dec 31, 2017 | 96.09% |